|
Volumn 3, Issue 2, 2004, Pages 48-53
|
Hepatocyte transplantation: state of the art and strategies for overcoming existing hurdles.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANIMAL;
CELL TRANSPLANTATION;
CHRONIC DISEASE;
CLINICAL TRIAL;
DISEASE MODEL;
DONOR;
GRAFT REJECTION;
GRAFT SURVIVAL;
HOSPITALIZATION;
HUMAN;
LIVER CELL;
LIVER FAILURE;
LIVER REGENERATION;
METHODOLOGY;
PHYSIOLOGY;
PROGNOSIS;
RESEARCH;
REVIEW;
RISK ASSESSMENT;
STANDARD;
SURVIVAL RATE;
TRANSPLANTATION;
TREATMENT OUTCOME;
ANIMALS;
CELL TRANSPLANTATION;
CHRONIC DISEASE;
CLINICAL TRIALS;
DISEASE MODELS, ANIMAL;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEPATOCYTES;
HUMANS;
LIVER FAILURE;
LIVER FAILURE, ACUTE;
LIVER REGENERATION;
PROGNOSIS;
RESEARCH;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
SURVIVAL RATE;
TISSUE DONORS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 4043048744
PISSN: 16652681
EISSN: None
Source Type: Journal
DOI: 10.1016/s1665-2681(19)32108-8 Document Type: Review |
Times cited : (63)
|
References (50)
|